{"entity":{"type":"insider","cik":"0001949621","url":"/insider/0001949621","json_url":"/insider/0001949621.json","name":"Eizen Joshua M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2025-01-07","last":"2026-07-10","span_basis":"filed_date"},"name_variants":[{"name":"Eizen Joshua M","source":"filing","n_filings":4,"first_seen":"2025-01-07","last_seen":"2026-07-10"}],"transactions":[{"id":5944437,"accession":"0001193125-26-301092","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-301092","line_url":"/filing/0001193125-26-301092#line-1","is_derivative":false,"issuer_cik":"0001880438","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001880438","owner_cik":"0001949621","owner_name":"Eizen Joshua M","owner_display_name":"Eizen Joshua M","owner_url":"/insider/0001949621","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5945.0,"shares_display":"5,945","price_per_share":4.172,"price_display":"4.17","price_state":"stated","total_value":24802.54,"total_display":"24,802.54","total_whole":"24,803","shares_owned_after":206554.0,"shares_owned_after_display":"206,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-08","filed_date":"2026-07-10","scope":"insider"},{"id":5796852,"accession":"0001193125-26-006763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-006763","line_url":"/filing/0001193125-26-006763#line-2","is_derivative":false,"issuer_cik":"0001880438","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001880438","owner_cik":"0001949621","owner_name":"Eizen Joshua M","owner_display_name":"Eizen Joshua M","owner_url":"/insider/0001949621","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6931.0,"shares_display":"6,931","price_per_share":1.012,"price_display":"1.01","price_state":"stated","total_value":7014.172,"total_display":"7,014.17","total_whole":"7,014","shares_owned_after":152499.0,"shares_owned_after_display":"152,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-07","scope":"insider"},{"id":5796850,"accession":"0001193125-26-006763","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006763","line_url":"/filing/0001193125-26-006763#line-1","is_derivative":false,"issuer_cik":"0001880438","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001880438","owner_cik":"0001949621","owner_name":"Eizen Joshua M","owner_display_name":"Eizen Joshua M","owner_url":"/insider/0001949621","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17923.0,"shares_display":"17,923","price_per_share":1.0014,"price_display":"1.00","price_state":"stated","total_value":17948.0922,"total_display":"17,948.09","total_whole":"17,948","shares_owned_after":159430.0,"shares_owned_after_display":"159,430","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4372451,"accession":"0001193125-25-270255","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-270255","line_url":"/filing/0001193125-25-270255#line-1","is_derivative":false,"issuer_cik":"0001880438","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001880438","owner_cik":"0001949621","owner_name":"Eizen Joshua M","owner_display_name":"Eizen Joshua M","owner_url":"/insider/0001949621","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2819.0,"shares_display":"2,819","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":3213.66,"total_display":"3,213.66","total_whole":"3,214","shares_owned_after":177353.0,"shares_owned_after_display":"177,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-04","filed_date":"2025-11-06","scope":"insider"},{"id":5029429,"accession":"0000950170-25-003152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-003152","line_url":"/filing/0000950170-25-003152#line-1","is_derivative":false,"issuer_cik":"0001880438","issuer_name":"AN2 Therapeutics, Inc.","issuer_ticker":"ANTX","issuer_name_source":null,"issuer_url":"/issuer/0001880438","owner_cik":"0001949621","owner_name":"Eizen Joshua M","owner_display_name":"Eizen Joshua M","owner_url":"/insider/0001949621","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9663.0,"shares_display":"9,663","price_per_share":1.341,"price_display":"1.34","price_state":"stated","total_value":12958.083,"total_display":"12,958.08","total_whole":"12,958","shares_owned_after":116672.0,"shares_owned_after_display":"116,672","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001880438","name":"AN2 Therapeutics, Inc.","url":"/issuer/0001880438","role":"Officer","n_filings":4,"first_seen":"2025-01-07","last_seen":"2026-07-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001949621","retrieved_at":"2026-08-26T07:44:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}